Manufacturing Companies in U.S. Offering COVID-19 Vaccine-Related Products

Manufacturing companies that offer vaccine-related products include Southeastern Lab Apparatus, Sonoco, Pharmaceutical Associates, NanoScreen, Alcami Corporation, Environmental Express, GY Packaging, Pantheon, Life Industries Corporation, and Lab Research Products. The government is planning to use the Defense Production Act (DPA) to increase the supply of low dead space syringes. However, experts predict that using DPA may not speed up the manufacturing process due to a lack of transparency in the supply chain and lack of production capacity across the country.

Companies that Manufacture Vaccine-Related Products

1. Southeastern Lab Apparatus

  • The company’s website is available here.
  • Southeastern Lab Apparatus is headquartered at 110 Walnut. Ln. North Augusta, SC 2986.
  • The company has 25 years of experience and specializes in laboratory products. It prides itself in offering competitive prices and short lead times.
  • It may be relevant to vaccine-related production because it offers both vials and syringes, according to Thomas Net.

2. Sonoco

  • The website is available here.
  • Sonoco is a global company with headquarters in Hartsville, South Carolina.
  • It offers a variety of packaging solutions, including consumer, industrial, protective, and healthcare packaging. Its healthcare products can be divided into medical device and clinical packaging and consumer healthcare packaging.
  • The company is relevant because its solutions are manufactured according to the medical industry’s standards and regulations. They include sterile and temperature-assured products. They may be used for packaging and transporting vaccines.

3. Pharmaceutical Associates, Inc.

  • The website is available here.
  • The company is headquartered at 1700 Perimeter Road, Greenville, SC 29605.
  • It specializes in producing generic liquid medicines. Its state-of-the-art manufacturing facility in Greenville has packaging capabilities.
  • The company was included because of its robust pharma manufacturing capabilities. Its profile is similar to Nephron Pharmaceuticals, which suggests that if it were necessary, it could assist in producing vaccine-related products.

4. NanoScreen, LLC

  • The website is available here.
  • The company is headquartered at 917 Commerce Circle, Hanahan, South Carolina 29410, US.
  • The company specializes in syringe heads, pipette tips, and liquid handling robots.
  • It is relevant because it offers syringe heads.

5. Alcami Corporation

  • Alcami’s website can be accessed here.
  • Its facility in South Carolina is located at 4221 Faber Place Drive in North Charleston, SC.
  • The company’s core specialties are sterile fill-finish development and manufacturing, oral solid dose development and manufacturing, and laboratory services.
  • It was selected because of its fill-finish manufacturing capabilities.

6. Environmental Express

  • The website can be accessed here.
  • The company is headquartered at 2345A Charleston Regional Parkway, Charleston, South Carolina 29492.
  • Its expertise includes manufacturing products related to wet chemistry, metals, chromatography, microbiology, organics, industrial hygiene, radiochemistry, sample collection, TCLP, filtration, general lab supplies, fluid handling, and calibration services.
  • Environmental Express is relevant because it offers general lab supplies (including vials) and fluid handling (for safe transportation).

7. GY Packaging

  • The website can be found here.
  • The company’s headquarters are at 202 Beechtree Blvd, Greenville, SC 29605.
  • GY Packaging has 25 years of experience in sterile and non-sterile medical packaging. Some of the applications include medical device trays, clamshells, ampule/vial packaging, implant trays, procedure kits, sterile presentation trays, diagnostic kits, transfer trays, and kit trays.
  • Apart from medical packaging, the company offers electronics and consumer packaging, as well as industrial applications.
  • It is relevant because it offers vial packaging.

8. Pantheon

  • The website can be accessed here.
  • Even though the company’s headquarters are in Dunham, North Carolina, it has a top-notch manufacturing facility in Florence, South California.
  • It’s on the campus that has 560 hectares. Its capabilities include technical development, pilot plant, clinical and commercial manufacturing.
  • Pantheon is a contract manufacturer that offers drug substance and drug product, clinical trial, and logistics services.
  • It is relevant due to the wide scope of pharmaceutical manufacturing contracting services. This makes it possible to contract the company for a variety of vaccine-related products, including raw materials.

9. Life Industries Corporation

  • Life Industries Corporation’s website is available here.
  • Its headquarters are located at 4060 Bridgeview Drive, North Charleston, SC 29405.
  • It offers custom manufacturing and packaging. The scope of its capabilities includes formulating, blending, filling, labeling, packaging, and assembling.
  • The company offers syringes and medical packaging. It is also engaged in COVID-19 response, though so far, it has not been focused on vaccine-related products.

10. Lab Research Products

  • LRP’s website can be found here.
  • The company is headquartered at 125 Varnfield Dr, Summerville, SC 29483, United States.
  • It offers temperature-controlled equipment for healthcare, laboratory and clinical research, pharmaceutical, and industrial segments. According to the website, its advantages include 25 years of experience and competitive prices.
  • LRP is relevant because it provides refrigerating solutions for vaccines.

The Impact of the Defense Production Act

The Shortage of Low Dead Space Syringes

  • The White House has announced that it will use the Defense Production Act to increase the production of low dead space syringes, which have unexpectedly become a preferred type for administering the vaccine.
  • Originally, it was believed that Pfizer vaccine vials only contain five doses of the vaccine. However, healthcare provides found out that each vial contains enough leftover vaccine for a sixth dose, as long as low dead space syringes are used. Such syringes minimize the amount of wasted substance.
  • As a result, the government and its contracted distributors promised to distribute “mega supply kits” across the country, which will include a mix of low dead space and regular syringes, allowing the extraction of 1,170 doses out of a package of 975 doses.
  • This development poses an issue to Biden’s administration. Before the pandemic, syringes of this type were a niche product, mostly used to avoid the waste of expensive medications or to limit the spread of blood-borne diseases among drug users.
  • At the same time, the announcement that low dead space syringes are a priority is recent. Many of the government contractors who manufacture syringes either don’t produce this type of syringes or can only produce them in a limited capacity.
  • Out of 286 million syringes that the US ordered last year, just 40 million were low dead syringes.
  • BD, the government’s main contractor for syringes, has already expressed its concern about the shortage of the low dead space type in the near future, despite the government investing to increase the company’s manufacturing capacity and having priority access to its products.

Expert Predictions on the Effectiveness of the Defense Production Act (DPA)

  • According to experts, it is likely that the Defense Production Act won’t be able to speed the distribution of the COVID-19 vaccine.
  • To a certain degree, the act could help ensure that manufacturers have enough raw materials. However, since lipid nanoparticles were never used on such a scale, production capacity may turn out to be a more significant issue.
  • Prashant Yadav, a medical supply chain expert from the Center for Global Development, says that building new plants or adjusting old ones will take weeks or months. At the same time, the Defense Production Act won’t be able to speed the process up.
  • Additionally, Pfizer and Moderna’s US manufacturing sites are already functioning at full capacity. Other locations that could produce mRNA vaccines are outside the country.
  • The above means that the government can’t tell Pfizer or Moderna to increase their production, while alternative manufacturers aren’t under its jurisdiction.
  • Therefore, according to Dr. Drew Weissman, a professor of medicine at the Perelman School of Medicine at the University of Pennsylvania, believes that the Defense Production Act won’t make much difference, especially considering the lack of transparency around the vaccine manufacturing process.
  • It is worth noting that there is a lot of criticism of the government. The critics believe that DPA should have been used much earlier to speed up the process and ensure more transparency between all involved parties.
Glenn is the Lead Operations Research Analyst at The Digital Momentum with experience in research, statistical data analysis and interview techniques. A holder of degree in Economics. A true specialist in quantitative and qualitative research.

The Future of COVID-19

Previous article

COVID-19 Vaccine Manufacturing

Next article

You may also like


Leave a reply

Your email address will not be published.